Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Eur J Pediatr ; 180(9): 2831-2838, 2021 Sep.
Article in English | MEDLINE | ID: mdl-33772623

ABSTRACT

Persistent pulmonary hypertension of the new-borns (PPHN) is one of the main etiologies of morbidity as well as mortality in neonates. Previous studies found that genetic polymorphisms in urea cycle enzymes are associated with PPHN. Few of the genetic polymorphisms in neonates have been recognized with PPHN. We aimed to find out the prevalence of the CPS-I gene polymorphism and to correlate the genotype with the serum nitric oxide (NO) levels in Egyptian neonates with idiopathic PPHN. We included neonates diagnosed with PPH (n = 150) while the control group included healthy neonates with matched age and sex (n = 100). The CPS-I gene polymorphism: A/C, trans-version substitution, rs4399666 genotype was identified using TaqMan-based quantitative PCR. The results revealed that the CPS-I A/C rs4399666 gene polymorphism and lower serum NO levels were significantly associated with idiopathic PPHN in neonates. In addition, serum NO level was significantly associated with an rs4366999 A/C variant gene in idiopathic PPHN (p = 0.001). Univariable regression analysis demonstrated that there was a significant association between CPS-I A/C rs4399666 CC and increased risk of PPHN (odd ratio, 95% CI of 1.8 (0.78 to 1.75), p-value = 0.04).Conclusion: We concluded that mutant CPS-I A/C rs4399666 minor variant especially the homozygous CC genotype is frequently distributed among the PPHN group. This demonstrates that the presence of mutant CPS-I rs4399666 does not necessarily predispose to the development of PPHN in neonates, but nonetheless, if the C allele is inherited in the homozygous CC genotype, it is associated with a higher risk of PPHN. What is Known: • Prior studies found that polymorphisms in urea cycle enzyme genes are associated with PPHN. • Association between CPS-1 gene polymorphisms is significantly associated with PPHN. What is New: • The prevalence of CPS-1, A/C trans-version substitution, rs4399666 gene polymorphism in Egyptian neonates presented with idiopathic PPHN. • Mutant CPS-I A/C rs4399666 especially the homozygous CC genotype is more frequently distributed among PPHN, and it is significantly associated with low serum nitric oxide level.


Subject(s)
Carbamoyl-Phosphate Synthase (Ammonia)/genetics , Hypertension, Pulmonary , Persistent Fetal Circulation Syndrome , Humans , Hypertension, Pulmonary/genetics , Infant, Newborn , Nitric Oxide , Persistent Fetal Circulation Syndrome/genetics , Phosphates , Polymorphism, Genetic
2.
Interdiscip Perspect Infect Dis ; 2018: 3727521, 2018.
Article in English | MEDLINE | ID: mdl-29706997

ABSTRACT

OBJECTIVE: We aimed to study the effect of visual observation of bacterial growth from handprints on healthcare workers' (HCWs) compliance with hand hygiene (HH). SETTINGS: Medical and postoperative cardiac surgery units. DESIGN: Prospective cohort study. SUBJECT: The study included 40 HCWs. INTERVENTION: Each HCW was interviewed on 3 separate occasions. The 1st interview was held to obtain a handprint culture before and after a session demonstrating the 7 steps of HH using alcohol-based hand rub, allowing comparison of results before and after HH. A 2nd interview was held 6 weeks later to obtain handprint culture after HH. A 3rd interview was held to obtain a handprint culture before HH. One month before implementation of handprint cultures and during the 12-week study period, monitoring of HCWs for compliance with HH was observed by 2 independent observers. MAIN RESULTS: There was a significant improvement in HH compliance following handprint culture interview (p < 0.001). The frequency of positive cultures, obtained from patients with suspected healthcare-associated infections, significantly declined (blood cultures: p = 0.001; wound cultures: p = 0,003; sputum cultures: p = 0.005). CONCLUSION: The visual message of handprint bacterial growth before and after HH seems an effective method to improve HH compliance.

3.
Electron Physician ; 8(9): 2897-2903, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27790341

ABSTRACT

AIM: The purpose of present study was to access the prevalence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with Juvenile Idiopathic Arthritis (JIA), and to investigate the clinical significance and diagnostic value of the anti-CCP antibodies in correlation with age, sex & activity. METHODS: This case-control study was performed on 50 patients with JIA in addition to 40 sex and age-matched children as a control group. The participants were recruited from rheumatology Outpatient Clinic of Cairo University Specialized Pediatric Hospital. Patients were subjected to full history taking, clinical examination, routine laboratory investigations and x-rays on involved joints. Both patients and controls underwent assay of anti-CCP antibodies by AxSYM Anti-CCP IgG Microparticle Enzyme Immunoassay (MEIA) which is a semi-quantitative determination of the IgG class of autoantibodies specific to cyclic citrullinated peptide (CCP) in patients' serum or plasma. Data were analyzed using Mann-Whitney U test, ANOVA, and independent-samples t-test by SPSS version 15. RESULTS: Anti-CCP positivity was identified amongst patients with JIA, particularly those JIA patients experiencing RF positive polyarticular disease onset. Above all, it is important that anti-CCP positivity and bone erosions, degree of joint damage, and ESR levels were significantly correlated. CONCLUSION: Anti-CCP could be utilized as a valuable marker in the polyarticular form of JIA to direct early, and could be aggressive therapeutic intervention.

4.
J Child Neurol ; 26(2): 136-41, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20606061

ABSTRACT

Nontraumatic coma in childhood is an important pediatric emergency with a wide range of primary etiologies. This prospective descriptive study of 100 consecutive pediatric nontraumatic coma cases was done to identify etiology, clinical profile, and predictive outcome in a pediatric emergency department at a tertiary care university hospital. Most frequent etiologies were metabolic (33%), central nervous system infections (28%), and intracranial hemorrhage (13%). In the emergency department, 50% of those patients died. Hypothermia, hypotension, flaccidity, and poor Glasgow coma scale at admission correlated significantly with mortality. After 48 hours of admission, poor pulse volume, poor Glasgow coma scale, abnormal respiratory pattern/apnea, and seizures correlated significantly with mortality. On logistic regression, poor Glasgow coma scale at admission, abnormal respiratory pattern, and seizures after 48 hours of admission were independent significant predictors of mortality. Metabolic causes are the most common etiology in pediatrics nontraumatic coma. Simple clinical signs were good predictors of outcome.


Subject(s)
Coma/etiology , Coma/mortality , Infections/complications , Intracranial Hemorrhages/complications , Metabolic Diseases/complications , Child , Child, Preschool , Coma/diagnosis , Egypt , Emergency Medical Services , Female , Glasgow Coma Scale , Humans , Infant , Logistic Models , Male , Prognosis , Prospective Studies
5.
Pediatr Emerg Care ; 26(12): 888-91, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21088638

ABSTRACT

UNLABELLED: Hyperammonemia is encountered frequently in acutely ill children presenting for emergency care with altered levels of consciousness (ALOC). Ammonia production, metabolism, and excretion are affected by different variables. Hyperammonemia may be a transient state or may signify more grave etiologies as inborn errors of metabolism. Levels of ammonia are also affected by proper sampling technique, transport, and analysis. OBJECTIVES: To determine the level of ammonia in acutely ill children with ALOC, identify causes of hyperammonemia, and correlate levels with illness severity and morbidity. DESIGN: Observational study. SETTING: Emergency department at Cairo University Specialized Paediatric Hospital. METHODS: Fifty cases of acutely ill pediatric patients with ALOC who presented to the emergency department were included in the study from 2008 through 2009. Emergency department patients (n = 20) with known diseases that may induce hyperammonemia were excluded. Patients were subjected to detailed history taking with emphasis on factors affecting ammonia levels and thorough clinical examination. A cohort group of age- and sex-matched children acted as a control group. RESULTS: The measured blood ammonia level ranged between 13 and 265 µmol/L, with a mean level of 95 µmol/L. Sixty percent of the children with ALOC had ammonia levels of greater than 75 µmol/L, with levels greater than 200 µmol/L seen in 6% of the studied sample. The study demonstrated a highly significant statistical difference between children with ALOC and control groups.There was no correlation between blood ammonia level and age. Correlations of ammonia levels were also conducted in comparison with etiological diagnoses and laboratory parameters with no statistical significance.There was no statistical significance between ammonia level and duration of illness, Sequential Organ Failure Assessment score, or Glasgow Coma Scale score/Morray Scale score. CONCLUSIONS: Clinicians should consider testing children with ALOC for hyperammonemia, provided that a clear understanding of its metabolism and factors controlling it are understood. Proper sampling must be ensured. Mild elevations of ammonia levels are fairly common, but exceedingly high levels should raise concern and may require further evaluation.


Subject(s)
Consciousness Disorders/blood , Critical Illness , Emergency Medical Services , Hyperammonemia , Ammonia/metabolism , Brain Damage, Chronic/epidemiology , Brain Damage, Chronic/etiology , Child , Child, Preschool , Consciousness Disorders/epidemiology , Consciousness Disorders/etiology , Egypt/epidemiology , Emergency Service, Hospital/statistics & numerical data , Female , Hospitals, University/statistics & numerical data , Humans , Hyperammonemia/blood , Hyperammonemia/diagnosis , Hyperammonemia/epidemiology , Hyperammonemia/etiology , Hyperammonemia/genetics , Infant , Infant, Newborn , Male , Matched-Pair Analysis , Metabolism, Inborn Errors/blood , Metabolism, Inborn Errors/diagnosis , Muscle Spasticity/epidemiology , Muscle Spasticity/etiology , Pneumonia/blood , Pneumonia/complications , Pneumonia/epidemiology , Sepsis/blood , Sepsis/complications , Sepsis/epidemiology , Specimen Handling , Urea/metabolism , Virus Diseases/blood , Virus Diseases/complications , Virus Diseases/epidemiology
6.
Transl Oncol ; 3(3): 170-5, 2010 Jun 01.
Article in English | MEDLINE | ID: mdl-20563258

ABSTRACT

Cervical cancer is known to metastasize primarily by the lymphatic system. Dissemination through lymphatic vessels represents an early step in regional tumor progression, and the presence of lymphatic metastasis is associated with a poor prognosis. In patients who have undergone a radical hysterectomy, lymphovascular space invasion (LVSI), assessed on hematoxylin and eosin-stained slides, is a major factor for adjuvant therapy in patients with cervical cancer. With the advent of a lymphatic endothelial cell-specific marker, such as D2-40, it is now possible to distinguish between blood and lymphatic space invasion (LSI). In this study, the utility of D2-40 was assessed for the detection of lymphatic vessel density (LVD) and identification of LSI. The expressions of vascular endothelial growth factor receptor-3 (VEGFR-3), VEGF-C, tyrosine receptor kinase-2, and angiopoietin-1 were assessed by immunohistochemical methods on 50 patients with squamous cell carcinoma of the cervix. Clinicopathologic characteristics, including pelvic lymph node metastasis, were correlated with the above histochemical findings. We found that lymphangiogenesis, measured by an increase in peritumoral LVD, was significantly associated with positive lymph node status (P < .005). VEGFR-3 expression was significantly associated with LVD (P < .05). D2-40 staining verified LSI (P = .03) and surpassed that of hematoxylin and eosin-identified LVSI (P = .54). In conclusion, lymphangiogenic markers, specifically LVD quantified by D2-40 and VEGFR-3, are independently associated with LSI and lymph node metastasis in patients with early squamous cell carcinoma of the cervix treated with radical hysterectomy and pelvic lymphadenectomy.

7.
Fertil Steril ; 93(1): 239-50, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19144333

ABSTRACT

OBJECTIVE: To evaluate the utility of gene therapy for uterine fibroids in the Eker rat model using an adenovirus-mediated delivery of a dominant-negative estrogen receptor gene (Ad-DNER). DESIGN: Animal study. SETTING: University animal laboratory. ANIMAL(S): Twenty-seven female Eker rats. INTERVENTION(S): We randomized Eker rats with magnetic resonance imaging (MRI)-confirmed uterine leiomyomas to a single treatment of direct intrafibroid injection with Ad-DNER, Ad-bacterial ss-galactosidase, or vehicle. MAIN OUTCOME MEASURE(S): Tumor volumes were determined by MRI scanning and caliper measurement. Samples of serum, fibroid tumors, and various organs were collected at 8, 15, and 30 days after treatment to assess treatment safety and efficacy. RESULT(S): The Ad-DNER treatment significantly decreased uterine fibroid volume by 45%, 80%, and 77.4% of pretreatment volume at days 8, 15, and 30, respectively, and modulated the expression of apoptosis-, proliferation-, and extracellular matrix-related genes' compared with control animals. The Ad-DNER did not produce any toxic effects in nontarget tissues. CONCLUSION(S): The Ad-DNER treatment shrinks Eker rats' fibroids, in part, via modulation of several estrogen-regulated genes. This safe gene therapy approach presents a promising conservative treatment option for women with symptomatic uterine fibroids.


Subject(s)
Adenoviridae/genetics , Estrogen Receptor alpha/genetics , Genetic Therapy/methods , Genetic Vectors , Leiomyoma/therapy , Uterine Neoplasms/therapy , Adenoviridae/immunology , Animals , Apoptosis/genetics , Cell Cycle Proteins/genetics , Cell Proliferation , Disease Models, Animal , Estrogen Receptor alpha/biosynthesis , Extracellular Matrix Proteins/genetics , Female , Gene Expression Regulation, Neoplastic , Genetic Therapy/adverse effects , Immunity, Humoral , Leiomyoma/genetics , Leiomyoma/immunology , Leiomyoma/metabolism , Leiomyoma/pathology , Magnetic Resonance Imaging , Mutation , Rats , Rats, Mutant Strains , Time Factors , Transfection , Tuberous Sclerosis Complex 2 Protein , Tumor Burden , Tumor Suppressor Proteins/genetics , Uterine Neoplasms/genetics , Uterine Neoplasms/immunology , Uterine Neoplasms/metabolism , Uterine Neoplasms/pathology
8.
Gynecol Obstet Invest ; 68(1): 19-32, 2009.
Article in English | MEDLINE | ID: mdl-19325244

ABSTRACT

BACKGROUND/AIMS: The objective of this study was to assess in vivo gene therapy of uterine leiomyomas in the Eker rat model using adenovirus (Ad)-mediated delivery of herpes simplex virus 1 thymidine kinase gene (HSV1TK) followed by ganciclovir (GCV) treatment. METHODS: We randomized 27 female Eker rats with MRI-confirmed uterine leiomyomas to a single treatment with direct intra-tumor injection of Ad-HSV1TK/GCV, Ad-LacZ/GCV, or medium alone. Samples were collected from tumors, other body organs, and blood at 10, 20, and 30 days after treatment to assess the safety and efficacy of the treatment. RESULTS: Ad-HSV1TK/GCV treatment significantly decreased uterine fibroid volume by 75 +/- 16, 58.7 +/- 6.3, and 67.5 +/- 27.5%, of the pretreatment volume at days 10, 20, and 30, respectively. Ad-HSV1TK/GCV increased caspase-3 activity, Bax expression, and TUNEL apoptosis marker, and it decreased cyclin D1, PCNA, Bcl2, and PARP protein expressions. Ad transfection induced local CD4+ and CD8+ infiltration and serum anti-Ad antibodies. Additionally, Ad transfection was tumor-localized and safe to non-target tissues. CONCLUSION: These studies demonstrate a marked efficiency and high safety for the Ad-HSV1TK/GCV therapeutic approach in the context of Eker rat uterine leiomyomas and provide essential preclinical data for the development of Ad-HSV1TK/GCV gene therapy for uterine fibroids.


Subject(s)
Adenoviridae/genetics , Genetic Therapy/methods , Leiomyoma/therapy , Thymidine Kinase/therapeutic use , Uterine Neoplasms/therapy , Animals , Antiviral Agents/therapeutic use , Caspase 3 , Disease Models, Animal , Female , Ganciclovir/therapeutic use , Genetic Therapy/adverse effects , Herpesvirus 1, Human/enzymology , Herpesvirus 1, Human/genetics , Leiomyoma/physiopathology , Rats , Thymidine Kinase/adverse effects , Thymidine Kinase/genetics , Uterine Neoplasms/physiopathology
9.
Cancer Chemother Pharmacol ; 62(5): 893-902, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18253735

ABSTRACT

PURPOSE: 2-Methoxyestradiol (2ME), an endogenous estradiol metabolite, was developed as a novel agent based on its antitumor activity and lack of toxicity. This study was designed to investigate the modulatory effect of 2ME on the antitumor effect of doxorubicin (Dox) in resistant breast tumor xenograft. Resistant MCF-7/Dox cells were implanted subcutaneously in nude mice METHODS: Treatment with Dox 5 mg/kg, 2ME 30 mg/kg and their combination continued twice a week for 2 weeks. RESULTS: Following 28 days from starting the treatment with Dox alone, the change in tumor volume from first day of treatment was 455.6 +/- 16.2%. Combined Dox and 2ME treatment significantly reduced tumor volume to 20.8 +/- 43%. Also, combined therapy resulted in enhanced tumor apoptotic and reduced proliferative activities relative to Dox alone. The apoptotic indices were 0.13 +/- 0.03 and 0.75 +/- 0.06 in Dox alone and Dox + 2ME groups, respectively. For Dox alone group, expression of the proliferative markers PCNA and Ki67 were 0.78 +/- 0.06 and 0.63 +/- 0.18, respectively. They were significantly reduced to 0.28 +/- 0.1 and 0.12 +/- 0.1 for their corresponding combined Dox and 2ME group. Interaction analysis clearly indicated that 2ME synergies antitumor, apoptotic and anti-proliferative activity of Dox. Examining body weight, hepatic and cardiac histopathology of the different treatment groups revealed no significant signs of toxicity. CONCLUSION: These findings suggest that 2ME reverses Dox resistance, with benign side effects profile.


Subject(s)
Antibiotics, Antineoplastic/pharmacology , Breast Neoplasms/drug therapy , Doxorubicin/pharmacology , Drug Resistance, Neoplasm/drug effects , Estradiol/analogs & derivatives , 2-Methoxyestradiol , Algorithms , Angiogenesis Inhibitors/pharmacology , Animals , Antibiotics, Antineoplastic/toxicity , Apoptosis/drug effects , Body Weight/drug effects , Cell Proliferation/drug effects , Doxorubicin/toxicity , Drug Synergism , Estradiol/pharmacology , Estradiol/toxicity , Female , Humans , Immunohistochemistry , In Situ Nick-End Labeling , Liver/pathology , Mice , Mice, Inbred BALB C , Mice, Nude , Myocardium/pathology , Xenograft Model Antitumor Assays
10.
Reprod Sci ; 15(2): 139-46, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18089589

ABSTRACT

Recent studies have suggested that germline stem cells may generate new follicles in the adult murine ovary. In this study, the authors use a pou5f1-enhanced green fluorescent protein (EGFP) transgenic mouse model to study the expression of stem and germ cell markers in adult murine ovaries. Immunohistochemical analyses and reverse transcription polymerase chain reaction were performed to detect the expression of mouse vasa homologue, stem cells factor receptor, stage-specific embryonic antigen 1, synaptonemal complex proteins, disrupted meiotic, and growth differentiation factor-9 in GFP+ ovarian tissues. GFP+ cell aggregates of nonfollicle structures were identified and isolated from adult B6.CBA-Tg(pou5f1-EGFP)2Mnn/J transgenic mouse ovaries. This study shows the presence of cell aggregates that are distinct from ovarian follicles and are coexpressing germline and stem cell surface markers in adult murine ovaries. These cell aggregates may represent a mixed population of germ cells and germline stem cells. Further research is necessary to evaluate the plasticity of the potential stem cell population in these cell aggregates.


Subject(s)
Germ Cells/metabolism , Octamer Transcription Factor-3/biosynthesis , Ovary/metabolism , Stem Cells/metabolism , Animals , Biomarkers/metabolism , Cell Cycle Proteins/biosynthesis , DEAD-box RNA Helicases/biosynthesis , DNA-Binding Proteins , Female , Lewis X Antigen/biosynthesis , Mice , Mice, Transgenic , Models, Animal , Nuclear Proteins/biosynthesis , Phosphate-Binding Proteins , Proto-Oncogene Proteins c-kit/biosynthesis
11.
Reproduction ; 134(6): 831-9, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18042640

ABSTRACT

Catechol-O-methyltransferase (COMT) enzyme catalyzes the methylation of the 2- or 4-hydroxyestrogens to 2- or 4-methoxyestrogens. Both the hydroxyestrogens and methoxyestrogens have been shown to block or enhance the effects of estrogen respectively. Our objective was to investigate the potential role of COMT in parturition and cervical ripening using a rat model. Immunohistochemistry was conducted to detect and localize the COMT protein in rat uterine tissues during pregnancy. We measured the longitudinal changes in urinary 2-hydroxyestrogen before, during, and after pregnancy in rats. Animal studies were conducted to determine the effect of treatment with a selective COMT inhibitor on (1) mifepristone-induced preterm birth and (2) cervical resistance to stretch in pregnant rats. The intensity of staining for the COMT protein differed within the luminal epithelium, uterine gland epithelium, endometrium, and myometrium during pregnancy. Levels of staining for the COMT protein in rat myometrium were highest on day 1 and lowest on days 8 and 13, but high levels returned by days 16 and 19 of pregnancy. The levels of urinary 2-hydroxyestrogen gradually increased in the first 2 weeks of pregnancy, peaked from days 16 to 18 of pregnancy, and then gradually returned to pre-pregnancy levels after delivery. The percentage of pups retained in the uterus of pregnant rats treated with both mifepristone and COMT inhibitor (48 +/- 15%) was significantly higher (P < 0.05) when compared with the value of pregnant rats treated with mifepristone alone (12 +/- 4%). The resistance to stretch was significantly higher (P < 0.05) in cervical tissues from the pregnant rats treated with COMT inhibitor (0.28) when compared with cervical tissues taken from rats treated with vehicle control (0.18). Modulation of COMT activity may play a role in the regulation of myometrial contractility and cervical ripening during pregnancy.


Subject(s)
Benzophenones/pharmacology , Catechol O-Methyltransferase Inhibitors , Cervix Uteri/enzymology , Obstetric Labor, Premature/prevention & control , Animals , Biomarkers/urine , Catechol O-Methyltransferase/analysis , Cervical Ripening/drug effects , Cervix Uteri/chemistry , Cervix Uteri/drug effects , Estradiol/analogs & derivatives , Estradiol/urine , Estriol/analogs & derivatives , Estriol/urine , Female , Hydroxyestrones/urine , Immunohistochemistry , In Vitro Techniques , Mifepristone , Models, Animal , Obstetric Labor, Premature/enzymology , Pregnancy , Rats , Rats, Sprague-Dawley
12.
J Clin Endocrinol Metab ; 92(8): 3285-91, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17535988

ABSTRACT

CONTEXT: Women with polycystic ovary syndrome (PCOS) have anovulation due to arrested follicular maturation. The substrate (2-hydroxyestrogen) and product (2-methoxyestrogen) of catechol-O-methyl transferase (COMT) have been shown to modulate proliferation and angiogenesis of granulosa cells. OBJECTIVE: The objective of the study was to evaluate COMT ovarian expression as well as the production of estrogen metabolites (2-hydroxyestrogen and 2-methoxyestrogen) in subjects with PCOS. DESIGN: Immunohistochemistry was used to assess COMT expression in ovarian tissues. Urinary levels of 10 different estrogens and estrogen metabolites were measured using enzyme-labeled immunoassays and/or liquid chromatography with tandem mass spectrometry. SETTING: The study was conducted at a tertiary university referral center. PATIENTS AND OTHER PARTICIPANTS: Ovarian tissues were obtained from six control subjects and six subjects with PCOS. Fasting first-void urinary samples were collected from 49 subjects with PCOS and 36 healthy control subjects. MAIN OUTCOME MEASURE(S): COMT protein expression in ovarian tissues was measured. Urinary levels of 2-hydroxyestrogen and 2-methoxyestrogen levels in PCOS patients were also measured. RESULTS: Whereas immunohistochemistry showed that COMT was expressed in ovaries from control and PCOS subjects, its expression was significantly higher in ovaries from subjects with PCOS, in both the follicular structures and ovarian stroma. The urinary 2-hydroxyestrogen level was significantly lower in subjects with PCOS, compared with normal controls (P = 0.009). Additionally, urinary 2-hydroxyestrogen levels negatively correlated with serum insulin levels in subjects with PCOS (r = -0.333, P =0 .031). CONCLUSIONS: Urinary 2-hydroxyestrogen is decreased in subjects with PCOS, which could be due in part to increased ovarian expression of COMT. Further studies are needed to ascertain the role of estrogen metabolism in PCOS before this information can be used in clinical settings.


Subject(s)
Estrogens, Catechol/urine , Polycystic Ovary Syndrome/urine , Adult , Body Mass Index , Catechol O-Methyltransferase/urine , Chromatography, High Pressure Liquid , Enzyme-Linked Immunosorbent Assay , Estrogens/urine , Female , Humans , Immunohistochemistry , Ovarian Follicle/enzymology , Ovarian Follicle/pathology , Ovary/enzymology , Spectrometry, Mass, Electrospray Ionization
SELECTION OF CITATIONS
SEARCH DETAIL
...